In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 31 for your search:
Drug:  ridaforolimus
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 13 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 8669-011, AP23573-07-302, NCT00538239

2.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 8669-024, AP23573-04-201, NCT00086125

3.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 8669-018, AP23573-04-202, 2004-002231-92, NCT00093080

4.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AP23573-04-204, NCT00110188

5.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 8669-019, AP23573-04-203, NCT00122343

6.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: MK-8669-009, AP23573-08-207, NCT00736970

7.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: MK-8669-007, AP23573-07-205, NCT00739830

8.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: I192, CAN-NCIC-IND192, ARIAD-CAN-NCIC-IND192, CDR0000614597, IND192, NCT00770185

9.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 8669-002, 2008_572, NCT00777959

10.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 13 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 8669-030, 2009_688, MK-8669-030, NCT01010672

11.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 8669-041, NCT01234857

12.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 8669-064, NCT01605396

13.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 8669-001, AP23573-02-101, NCT00060632

14.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 8669-013, AP23573-02-102, NCT00060645

15.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 8669-023, AP23573-04-103, NCT00087451

16.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 8669-016, AP23573-05-106, NCT00112372

17.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 8669-015, AP23573-05-107, NCT00288431

18.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 8669-003, 2008_011, NCT00694083

19.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 1 to 17
Sponsor: Pharmaceutical / Industry
Protocol IDs: 8669-028, SUN08-01, AP23573-07-110, NCT00704054

20.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 2008_538, MK8669-004, NCT00730379

21.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 8669-010, AP23573-08-111, NCT00781846

22.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 8669-037, 2009_569, NCT00874731

23.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: 2009_706, MK8669-046, NCT01043887

24.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 8669-044, 2010_511, NCT01071304

25.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 09-034, NCI-2010-01907, NCT01169532
1   
New Search